Since the opening of its Brussels office in 2015, the EPA consolidated its role as a key stakeholder in the EU policy arena and strengthened its advocacy activities to contribute to the development of evidence-based policies in the field of mental health. In particular, the EPA strengthened the role of the EPA Council of NPAs and build strategic partnerships with other actors active in the field of mental health, such as the patient and family organisations.
- Official representation of patient organisation GAMIAN-Europe and family organisation EUFAMI in the EPA Board (since 2018)
- Joint policy events such as the EPA-GAMIAN Europe meeting at the European Parliament on “New horizons for person-centred research and care” (Brussels, 3 December 2018), as part of the work of the European Parliament Interest Group on Mental Health, Wellbeing and Brain Disorders
- Launch of the annual EPA Forum, regularly hosted ahead of the European Congress of Psychiatry to bring together scientists, clinicians and policy makers and discuss important issues in the field of mental health in Europe
- Collaborating with relevant European-level organisations to advocate for better mental health care and improve research and care across countries
Latest policy documents
Click on the buttons below for information about recent policy documents produced with EPA involvement.
Visit the Publications & Research section of the website to find out more about EPA publications in the field of mental health policy.